PHARMALYNX LTD
Significant control: Peter John Jones (25–50%), Sarah Louise Jones (25–50%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
What does Pharmalynx Ltd sell?
Registered activity: Other professional, scientific and technical activities n.e.c. (SIC 74909). We’re building product and service lists for UK companies. Get this one when it’s ready.
Summary
PHARMALYNX LTD is an active private limited company (company number 09201508) incorporated on 3 September 2014, registered in Callington. Its registered activity is other professional, scientific and technical activities n.e.c. (SIC 74909). Latest micro accounts cover the period ending 30 September 2025, showing net assets of £1,927, with 1 employee on average. As micro-entity accounts, no profit and loss account is filed, so turnover and profit are not public. Net assets fell 39% on the prior period (£3,183).
By net assets it sits in the lower half of 7,714 comparable companies in Other (median £6,373, upper quartile £46k).
Ownership and control
- Mr Peter John Jones
- owns 25–50% of shares
- holds 25–50% of voting rights
- Mrs Sarah Louise Jones
- owns 25–50% of shares
- holds 25–50% of voting rights
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
Key dates
- Incorporated
- 3 September 201412 yrs ago
- Next accounts due
- 30 June 2027in 250 days
- Confirmation statement due
- 17 September 2027in 329 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
Activity
- SIC 74909
- Other professional, scientific and technical activities n.e.c.
- Accounts type
- Micro Entity
- Size band
- MicroCompanies Act thresholds
Financials
| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 30 September 2025 | £1,927 | — | — | £8,718 | — | — | 1 |
| 30 September 2024 | £3,183 | — | — | £7,159 | — | — | 2 |
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing; micro-entity accounts contain no profit and loss account.
Filing and accounts signals
- Net assets above zeroNet assets £1,927 at 30 September 2025
- Net assets down 25% or more on the prior period-39.5% vs prior period
- Incorporated five or more years agoIncorporated 3 September 2014
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
Timeline
- Confirmation statement duein 329 days
- Next accounts duein 250 days
- Accounts period endNet assets £1,927 · micro accounts
- Accounts period endNet assets £3,183 · micro accounts
- Incorporated
Similar companies in the UK
- ROCHFORD (SCOTLAND) LIMITEDForres · inc. Sept 2014
- AIR AND SPACE EVIDENCE LTDDevizes · inc. Sept 2014
- KARL CHAPMAN LTDHarrogate · inc. Sept 2014
- ALAMO MONITORING LIMITEDPlymouth · inc. Sept 2014
- MBUYU CAPITAL PARTNERS LIMITEDHereford · inc. Sept 2014
- A DIGITAL EDGE LIMITEDDorchester · inc. Sept 2014
All companies incorporated on 3 September 2014 · in Sept 2014.
Reminders for PHARMALYNX LTD
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.